IP Verse

Nicotinamide Mononucleotide Derivatives And Their Uses

PatentPatent Analysis

EP3331894

METRO BIOTECH
Application Number
EP16833957A
Filing Date
Aug 5, 2016
Status
Opposition Rejected
Jun 9, 2023
Grant Date
Feb 17, 2021
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3331894B1 was granted to Metro Biotech on Feb 17, 2021 following the initial filing on Aug 5, 2016 under the application number EP16833957A . The current legal status of the patent is Opposition Rejected.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

PLASSERAUDNov 17, 2021 -

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents